AI-Based Virtual Screening of NLRP3 Inflammasome-Targeting Drug Candidates for Alzheimer’s Disease and Evaluation of Blood–Brain Barrier Permeability. EMSGH. 2026;3:38-47. doi:10.70267/emsgh.v3.3847